DNB Asset Management AS Reduces Holdings in Revvity Inc. $RVTY

DNB Asset Management AS lowered its position in shares of Revvity Inc. (NYSE:RVTY) by 91.1% during the fourth quarter, HoldingsChannel reports. The firm owned 2,068 shares of the company’s stock after selling 21,244 shares during the period. DNB Asset Management AS’s holdings in Revvity were worth $200,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Byrne Asset Management LLC grew its position in shares of Revvity by 0.9% during the fourth quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock worth $1,078,000 after buying an additional 100 shares in the last quarter. Allworth Financial LP grew its position in shares of Revvity by 8.9% during the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock worth $123,000 after buying an additional 104 shares in the last quarter. Trust Point Inc. grew its position in shares of Revvity by 3.8% during the fourth quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock worth $311,000 after buying an additional 117 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Revvity by 26.2% during the fourth quarter. Farther Finance Advisors LLC now owns 698 shares of the company’s stock worth $68,000 after buying an additional 145 shares in the last quarter. Finally, Mackenzie Financial Corp grew its position in shares of Revvity by 1.7% during the third quarter. Mackenzie Financial Corp now owns 8,955 shares of the company’s stock worth $785,000 after buying an additional 154 shares in the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Up 0.6%

RVTY stock opened at $95.41 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $118.30. The firm has a fifty day moving average price of $90.54 and a two-hundred day moving average price of $96.96. The firm has a market cap of $10.64 billion, a price-to-earnings ratio of 45.65, a PEG ratio of 2.04 and a beta of 1.05.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. During the same quarter in the previous year, the firm earned $1.01 earnings per share. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Research analysts predict that Revvity Inc. will post 5.33 EPS for the current year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s payout ratio is presently 13.40%.

Analyst Ratings Changes

A number of analysts have recently weighed in on RVTY shares. Stifel Nicolaus decreased their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a research report on Wednesday, May 6th. Wells Fargo & Company raised their price target on shares of Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Robert W. Baird set a $117.00 price target on shares of Revvity in a research report on Wednesday, May 6th. JPMorgan Chase & Co. cut their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Finally, Evercore upped their price objective on Revvity from $112.00 to $118.00 and gave the company an “outperform” rating in a research note on Tuesday, February 3rd. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.